Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auricular Point Stimulation Plus Dexamethasone for CINV in Breast Cancer
NCT07716176Phase 3Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Proportion of patients experiencing nausea. Started Dec 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07716176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07716176.